Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $406.81 | 17 | 53.8% |
| Education | $350.00 | 1 | 46.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic, Inc. | $350.00 | 1 | $0 (2022) |
| ACADIA Pharmaceuticals Inc | $50.06 | 2 | $0 (2024) |
| Amneal Pharmaceuticals LLC | $45.62 | 2 | $0 (2024) |
| Lilly USA, LLC | $45.34 | 2 | $0 (2024) |
| CSL Behring | $35.61 | 1 | $0 (2023) |
| Integra LifeSciences Corporation | $32.15 | 1 | $0 (2022) |
| Grifols USA, LLC | $29.06 | 1 | $0 (2023) |
| UCB, Inc. | $27.73 | 1 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $26.07 | 1 | $0 (2024) |
| Lundbeck LLC | $23.36 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $248.86 | 11 | ACADIA Pharmaceuticals Inc ($50.06) |
| 2023 | $125.80 | 5 | CSL Behring ($35.61) |
| 2022 | $382.15 | 2 | Medtronic, Inc. ($350.00) |
All Payment Transactions
18 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/05/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $25.94 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 10/29/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $28.32 | General |
| Category: NEUROLOGY | ||||||
| 08/27/2024 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: NEUROLOGY | ||||||
| 08/13/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $24.12 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 07/30/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 07/12/2024 | ARGENX US, INC. | VYVGART (Drug) | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: Immunology | ||||||
| 05/13/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $27.73 | General |
| Category: Neurology | ||||||
| 04/25/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $26.07 | General |
| Category: Rare Disease | ||||||
| 03/26/2024 | Lilly USA, LLC | AMYVID (Drug) | Food and Beverage | In-kind items and services | $23.35 | General |
| Category: Neuroscience | ||||||
| 01/16/2024 | Otsuka America Pharmaceutical, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: NEUROLOGY | ||||||
| 01/10/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Neurology | ||||||
| 11/09/2023 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $23.36 | General |
| Category: NEUROLOGY | ||||||
| 10/17/2023 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $35.61 | General |
| Category: Immunology | ||||||
| 10/05/2023 | Lilly USA, LLC | AMYVID (Drug) | Food and Beverage | In-kind items and services | $21.99 | General |
| Category: Neuroscience | ||||||
| 09/21/2023 | Grifols USA, LLC | Gamunex-C (Biological) | Food and Beverage | In-kind items and services | $29.06 | General |
| Category: Immunology and Neurology | ||||||
| 09/14/2023 | EMD Serono, Inc. | MAVENCLAD (Drug) | Food and Beverage | Cash or cash equivalent | $15.78 | General |
| Category: Neurology | ||||||
| 03/07/2022 | Medtronic, Inc. | PRESTIGE LP CERVICAL DISC SYSTEM (Device) | Education | In-kind items and services | $350.00 | General |
| Category: Cervical | ||||||
| 03/03/2022 | Integra LifeSciences Corporation | CODMAN CERTAS (Device), CUSA CLARITY, CODMAN HAKIM | Food and Beverage | In-kind items and services | $32.15 | General |
| Category: Neuro Critical Care | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 90 | 110 | $19,475 | $10,658 |
| 2022 | 4 | 106 | 109 | $25,710 | $12,727 |
| 2021 | 4 | 83 | 87 | $22,775 | $11,699 |
| 2020 | 4 | 94 | 95 | $26,980 | $13,687 |
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 32 | 49 | $6,615 | $3,740 | 56.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 22 | 25 | $4,500 | $2,656 | 59.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $5,130 | $2,617 | 51.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 17 | 17 | $3,230 | $1,646 | 50.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 44 | 44 | $15,400 | $7,272 | 47.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 17 | 17 | $5,150 | $2,469 | 47.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 23 | 24 | $2,160 | $1,605 | 74.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 22 | 24 | $3,000 | $1,380 | 46.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 34 | 34 | $11,900 | $5,357 | 45.0% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 22 | 22 | $7,700 | $4,287 | 55.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 16 | 20 | $1,800 | $1,440 | 80.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 11 | 11 | $1,375 | $614.70 | 44.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 45 | 45 | $15,750 | $7,785 | 49.4% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 24 | 24 | $8,400 | $4,199 | 50.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 14 | 14 | $1,750 | $874.44 | 50.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 11 | 12 | $1,080 | $829.41 | 76.8% |
About Dr. Melvin Snyder, M.D
Dr. Melvin Snyder, M.D is a Specialist healthcare provider based in Torrance, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1942388962.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Melvin Snyder, M.D has received a total of $756.81 in payments from pharmaceutical and medical device companies, with $248.86 received in 2024. These payments were reported across 18 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($406.81).
As a Medicare-enrolled provider, Snyder has provided services to 373 Medicare beneficiaries, totaling 401 services with total Medicare billing of $48,771. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Location Torrance, CA
- Active Since 11/01/2006
- Last Updated 06/10/2020
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1942388962
Products in Payments
- PRESTIGE LP CERVICAL DISC SYSTEM (Device) $350.00
- NUPLAZID (Drug) $50.06
- AMYVID (Drug) $45.34
- Hizentra (Biological) $35.61
- CODMAN CERTAS (Device) $32.15
- Gamunex-C (Biological) $29.06
- CREXONT (Drug) $28.32
- Briviact (Drug) $27.73
- ULTOMIRIS (Biological) $26.07
- VYEPTI (Biological) $23.36
- BOTOX (Biological) $21.91
- VYVGART (Drug) $19.47
- NUEDEXTA (Drug) $18.15
- RYTARY (Drug) $17.30
- Leqembi (Drug) $16.50
- MAVENCLAD (Drug) $15.78
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Torrance
Dr. William Kim, M.d, M.D
Specialist — Payments: $167,651
Dr. Peter Borden, Md, MD
Specialist — Payments: $88,354
Dr. Sutha Sachar, Md, MD
Specialist — Payments: $23,126
Michael Arnstein, M.d, M.D
Specialist — Payments: $13,983
Dr. Hala Koudsi, M.d, M.D
Specialist — Payments: $9,366
Dr. Munish Lal, Md, MD
Specialist — Payments: $6,495